Atlas Trials

Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced Pancreatic Cancer With KRAS G12D Mutation

Clinical trial NCT07689539 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07689539
Sponsor
Jiangxi Kvvit Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2026-09-01
Primary completion
2028-07-01
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.